Molecular subtype approximated by quantitative estrogen receptor, progesterone receptor and Her2 can predict the prognosis of breast cancer.


AIMS AND BACKGROUND To investigate the clinicopathological characteristics and prognosis of breast cancer subtypes classified by quantitative estrogen receptor (ER), progesterone receptor (PR), and Her2. METHODS AND STUDY DESIGN 923 patients with primary breast cancer having a median age of 53 years who were treated at the Cancer Hospital of Fudan… (More)